Reference,Reference: DOI,Assay,Section,Infection (CP),Months,Host,Control,Control: NT50 Cmp,Control: NT50 GeoMean,Control: NT50 GSD,Variant,Variant: Pos,Variant: Mutations,# Results,Potency: NT50 Cmp,Potency: NT50 GeoMean,Potency: NT50 GSD,Fold Reduction: Cmp,Fold Reduction: Median
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1C,L452R variants,1m,Human,Wild Type (B.1),=,164.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,546.0,1.0,=,0.3
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1C,L452R variants,1m,Human,Wild Type (B.1),=,330.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,160.0,1.0,=,2.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1C,L452R variants,1m,Human,Wild Type (B.1),=,228.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,74.0,1.0,=,3.1
Neerukonda21,10.3390/v13122485,Pseudovirus (HIV),Figure 1C,L452R variants,1m,Human,Wild Type (B.1),=,286.0,1.0,Delta/K417N,19,T19R + T95I + G142D + E156G + Δ157-158 + W258L + K417N + L452R + T478K + K558N + P681R + D950N,1,=,177.0,1.0,=,1.6